My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 39

    1.

    Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis.

    Zheng SR, Guo GL, Zhang W, Huang GL, Hu XQ, Zhu J, Huang QD, You J, Zhang XH.

    Oncol Rep. 2012 Apr;27(4):1149-55. doi: 10.3892/or.2012.1634. Epub 2012 Jan 12.

    PMID:
    22245916
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.

    Pectasides D, Papaxoinis G, Kotoula V, Fountzilas H, Korantzis I, Koutras A, Dimopoulos AM, Papakostas P, Aravantinos G, Varthalitis I, Kosmidis P, Skarlos D, Bournakis E, Bafaloukos D, Kalofonos HP, Kalogeras KT, Fountzilas G.

    Oncol Rep. 2012 Jan;27(1):216-24. doi: 10.3892/or.2011.1504. Epub 2011 Oct 13.

    PMID:
    22025320
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    miRNAs in breast cancer tumorigenesis (Review).

    Zhang ZJ, Ma SL.

    Oncol Rep. 2012 Apr;27(4):903-10. doi: 10.3892/or.2011.1611. Epub 2011 Dec 23. Review.

    PMID:
    22200848
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.

    González-Villasana V, Nieves-Alicea R, McMurtry V, Gutiérrez-Puente Y, Tari AM.

    Oncol Rep. 2012 Mar;27(3):861-6. doi: 10.3892/or.2011.1600. Epub 2011 Dec 21.

    PMID:
    22200873
    [PubMed - in process]

    Related citations

    5.

    Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.

    Sheng XJ, Zhou YQ, Song QY, Zhou DM, Liu QC.

    Oncol Rep. 2012 Apr;27(4):1011-8. doi: 10.3892/or.2011.1596. Epub 2011 Dec 19.

    PMID:
    22200669
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.

    Knutson AK, Welsh J, Taylor T, Roy S, Wang WL, Tenniswood M.

    Oncol Rep. 2012 Mar;27(3):849-53. doi: 10.3892/or.2011.1590. Epub 2011 Dec 12.

    PMID:
    22159450
    [PubMed - in process]

    Related citations

    7.

    Association of aberrant DNA methylation with clinicopathological features in breast cancer.

    Tserga A, Michalopoulos NV, Levidou G, Korkolopoulou P, Zografos G, Patsouris E, Saetta AA.

    Oncol Rep. 2012 May;27(5):1630-8. doi: 10.3892/or.2011.1576. Epub 2011 Dec 5.

    PMID:
    22159596
    [PubMed - in process]

    Related citations

    8.

    A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.

    Trinh XB, Sas L, Van Laere SJ, Prové A, Deleu I, Rasschaert M, Van de Velde H, Vinken P, Vermeulen PB, Van Dam PA, Wojtasik A, De Mesmaeker P, Tjalma WA, Dirix LY.

    Oncol Rep. 2012 Mar;27(3):657-63. doi: 10.3892/or.2011.1562. Epub 2011 Nov 24.

    PMID:
    22134540
    [PubMed - in process]

    Related citations

    9.

    Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.

    Liu CM, Lee WC, Yu CY, Lan KL, Chang CH, Ting G, Lee TW.

    Oncol Rep. 2012 Mar;27(3):678-84. doi: 10.3892/or.2011.1557. Epub 2011 Nov 22.

    PMID:
    22109644
    [PubMed - in process]

    Related citations

    10.

    Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells.

    Onishi I, Lin PJ, Numata Y, Austin P, Cipollone J, Roberge M, Roskelley CD, Numata M.

    Oncol Rep. 2012 Feb;27(2):311-7. doi: 10.3892/or.2011.1542. Epub 2011 Nov 9.

    PMID:
    22076128
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.

    Kataoka M, Yamaguchi Y, Moriya Y, Sawada N, Yasuno H, Kondoh K, Evans DB, Mori K, Hayashi S.

    Oncol Rep. 2012 Feb;27(2):303-10. doi: 10.3892/or.2011.1541. Epub 2011 Nov 9.

    PMID:
    22076074
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    PI-PLCβ1 gene copy number alterations in breast cancer.

    Molinari C, Medri L, Follo MY, Piazzi M, Mariani GA, Calistri D, Cocco L.

    Oncol Rep. 2012 Feb;27(2):403-8. doi: 10.3892/or.2011.1529. Epub 2011 Nov 8.

    PMID:
    22076473
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    SNPs/pools: a methodology for the identification of relevant SNPs in breast cancer epidemiology.

    Silva SN, Guerreiro D, Gomes M, Azevedo AP, Bezerra De Castro G, Rueff J, Gaspar JF.

    Oncol Rep. 2012 Feb;27(2):511-6. doi: 10.3892/or.2011.1523. Epub 2011 Oct 24.

    PMID:
    22024983
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.

    Han J, Kim S, Yang JH, Nam SJ, Lee JE.

    Oncol Rep. 2012 Feb;27(2):517-22. doi: 10.3892/or.2011.1511. Epub 2011 Oct 20.

    PMID:
    22020547
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Genipin, a constituent of Gardenia jasminoides Ellis, induces apoptosis and inhibits invasion in MDA-MB-231 breast cancer cells.

    Kim ES, Jeong CS, Moon A.

    Oncol Rep. 2012 Feb;27(2):567-72. doi: 10.3892/or.2011.1508. Epub 2011 Oct 20.

    PMID:
    22020372
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.

    Rhodes LV, Nitschke AM, Segar HC, Martin EC, Driver JL, Elliott S, Nam SY, Li M, Nephew KP, Burow ME, Collins-Burow BM.

    Oncol Rep. 2012 Jan;27(1):10-6. doi: 10.3892/or.2011.1488. Epub 2011 Oct 4.

    PMID:
    21971930
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Effect of berberine on p53 expression by TPA in breast cancer cells.

    Kim S, Han J, Kim NY, Lee SK, Cho DH, Choi MY, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE.

    Oncol Rep. 2012 Jan;27(1):210-5. doi: 10.3892/or.2011.1480. Epub 2011 Sep 29.

    PMID:
    21964832
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.

    Bernardi MA, Logullo AF, Pasini FS, Nonogaki S, Blumke C, Soares FA, Brentani MM.

    Oncol Rep. 2012 Jan;27(1):28-38. doi: 10.3892/or.2011.1477. Epub 2011 Sep 28.

    PMID:
    21956537
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.

    Böhm D, Keller K, Wehrwein N, Lebrecht A, Schmidt M, Kölbl H, Grus FH.

    Oncol Rep. 2011 Nov;26(5):1051-6. doi: 10.3892/or.2011.1420. Epub 2011 Aug 11.

    PMID:
    21837365
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Protein expression of the Ets transcription factor Elf-1 in breast cancer cells is negatively correlated with histological grading, but not with clinical outcome.

    Gerloff A, Dittmer A, Oerlecke I, Holzhausen HJ, Dittmer J.

    Oncol Rep. 2011 Nov;26(5):1121-5. doi: 10.3892/or.2011.1409. Epub 2011 Aug 2.

    PMID:
    21811762
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk